null

SMILES Cn1c2occ(CC(=O)Nc3nc(cs3)-c3cc(F)cc(c3)C(F)(F)F)c2c(=O)n(C)c1=O

InChI Key InChIKey=XYLQLKFUIGUGMF-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 191709   

TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
GLENMARK PHARMACEUTICALS S.A.

US Patent
LigandPNGBDBM191709(US9186360, 55)copy SMILEScopy InChI
Affinity DataIC50: 2.15nMT: 2°CAssay Description:The inhibition of TRPA1 receptor activation was measured as inhibition of allylisothiocyanate (AITC) induced cellular uptake of radioactive calcium. ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TX3D5QUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
GLENMARK PHARMACEUTICALS S.A.

US Patent
LigandPNGBDBM191709(US9186360, 55)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:The inhibition of TRPA1 receptor activation was measured as inhibition of allylisothiocyanate (AITC) induced cellular uptake of radioactive calcium. ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TX3D5QUS Patent
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
GLENMARK PHARMACEUTICALS S.A.

US Patent
LigandPNGBDBM191709(US9186360, 55)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:The inhibition of TRPA1 receptor activation was measured as inhibition of allylisothiocyanate (AITC) induced cellular uptake of radioactive calcium. ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TX3D5QUS Patent
TargetTransient receptor potential cation channel subfamily V member 4(Homo sapiens (Human))
GLENMARK PHARMACEUTICALS S.A.

US Patent
LigandPNGBDBM191709(US9186360, 55)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:The inhibition of TRPA1 receptor activation was measured as inhibition of allylisothiocyanate (AITC) induced cellular uptake of radioactive calcium. ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TX3D5QUS Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
GLENMARK PHARMACEUTICALS S.A.

US Patent
LigandPNGBDBM191709(US9186360, 55)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:The inhibition of TRPA1 receptor activation was measured as inhibition of allylisothiocyanate (AITC) induced cellular uptake of radioactive calcium. ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TX3D5QUS Patent